Medicare's requirement for research participation as a condition of coverage: is it ethical? - PubMed (original) (raw)

. 2006 Aug 23;296(8):988-91.

doi: 10.1001/jama.296.8.988.

Affiliations

• PMID: 16926358
• DOI: 10.1001/jama.296.8.988

Medicare's requirement for research participation as a condition of coverage: is it ethical?

Steven D Pearson et al. JAMA. 2006.

No abstract available

PubMed Disclaimer

Comment in

• Medicare requirement for research participation.
  Groeneveld PW. Groeneveld PW. JAMA. 2006 Dec 27;296(24):2923-4; author reply 2924-5. doi: 10.1001/jama.296.24.2923-b. JAMA. 2006. PMID: 17190890 No abstract available.
• Medicare requirement for research participation.
  Brezis M, Lehmann LS. Brezis M, et al. JAMA. 2006 Dec 27;296(24):2924; author reply 2924-5. doi: 10.1001/jama.296.24.2924-a. JAMA. 2006. PMID: 17190891 No abstract available.

Similar articles

• Medicare requirement for research participation.
  Brezis M, Lehmann LS. Brezis M, et al. JAMA. 2006 Dec 27;296(24):2924; author reply 2924-5. doi: 10.1001/jama.296.24.2924-a. JAMA. 2006. PMID: 17190891 No abstract available.
• Medicare requirement for research participation.
  Groeneveld PW. Groeneveld PW. JAMA. 2006 Dec 27;296(24):2923-4; author reply 2924-5. doi: 10.1001/jama.296.24.2923-b. JAMA. 2006. PMID: 17190890 No abstract available.
• Focus on locus: evolution of Medicare's local coverage policy.
  Foote SB. Foote SB. Health Aff (Millwood). 2003 Jul-Aug;22(4):137-46. doi: 10.1377/hlthaff.22.4.137. Health Aff (Millwood). 2003. PMID: 12889761
• Medicare's coverage with study participation policy: clinical trials or tribulations?
  Carnahan SJ. Carnahan SJ. Yale J Health Policy Law Ethics. 2007 Summer;7(2):229-72. Yale J Health Policy Law Ethics. 2007. PMID: 17824405 Review. No abstract available.
• Medicare's preventive services.
  Scala-Foley MA, Caruso JT, Archer D, Reinhard SC. Scala-Foley MA, et al. Am J Nurs. 2004 Apr;104(4):73-5. doi: 10.1097/00000446-200404000-00024. Am J Nurs. 2004. PMID: 15171118 Review. No abstract available.

Cited by

• Using comparative effectiveness research to inform policy and practice in the UK HHS: past, present and future.
  Chalkidou K, Walley T. Chalkidou K, et al. Pharmacoeconomics. 2010;28(10):799-811. doi: 10.2165/11535260-000000000-00000. Pharmacoeconomics. 2010. PMID: 20831288 Review.
• When research seems like clinical care: a qualitative study of the communication of individual cancer genetic research results.
  Miller FA, Giacomini M, Ahern C, Robert JS, de Laat S. Miller FA, et al. BMC Med Ethics. 2008 Feb 22;9:4. doi: 10.1186/1472-6939-9-4. BMC Med Ethics. 2008. PMID: 18294373 Free PMC article.
• Reference pricing with evidence development: a way forward for proton therapy.
  Bekelman JE, Hahn SM. Bekelman JE, et al. J Clin Oncol. 2014 May 20;32(15):1540-2. doi: 10.1200/JCO.2014.55.6613. Epub 2014 Apr 21. J Clin Oncol. 2014. PMID: 24752049 Free PMC article. No abstract available.
• Cost, coverage, and comparative effectiveness research: the critical issues for oncology.
  Pearson SD. Pearson SD. J Clin Oncol. 2012 Dec 1;30(34):4275-81. doi: 10.1200/JCO.2012.42.6601. Epub 2012 Oct 15. J Clin Oncol. 2012. PMID: 23071229 Free PMC article. Review.
• The case of vertebroplasty trials: promoting a culture of evidence-based procedural medicine.
  Miller FG, Kallmes DF. Miller FG, et al. Spine (Phila Pa 1976). 2010 Nov 1;35(23):2023-6. doi: 10.1097/BRS.0b013e3181ecd393. Spine (Phila Pa 1976). 2010. PMID: 20938382 Free PMC article.

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Silverchair Information Systems

• Medical

  • MedlinePlus Health Information